The lack of lactose-fermenting ability of Salmonella species has long been regarded as one of the important attributes of salmonellae that differentiate salmonellae from members of several other genera of Enterobacteriaceae. Since 1959, frequent incidences of salmonellosis due to lactose-fermenting strains have been reported from the United States, Brazil, Canada, and Japan (1, 9, 14, 24) . In these cases, including two outbreaks in Canada and Brazil, the isolates belonged to serogroups B, C1, C2, D, E1, or E4. Lactose-fermenting ability in salmonellae usually causes delay in the proper identification of such strains.
Among the lactose-fermenting isolates, strain ST-2 was the only strain of naturally occurring Salmonella typhi hitherto reported in the literature. Strain ST-2 was first reported by Baron et al. (4) in 1959 as a high frequency recombinant strain compatible with many strains of Salmonella, Shigella, and Escherichia species. However, Baron et al. did not mention its source of isolation. Falkow and Baron (8) later reported that ST-2 was isolated from the stool of a patient with gastroenteritis. In 1965, Massachusetts General Hospital reported a case of classical typhoid fever in a laboratory glassware washer due to a lactose-fermenting S. typhi strain (11) .
Since the isolates from the blood and urine of the patient did not differ from the laboratory strain labeled as 643 lac+, the infection was thought to be laboratory acquired. Strain 643 lac+ was derived from typical S. typhi 643 treated with the episome of strain ST-2 during the course of a genetic experiment.
Recently, we encountered an adult patient with typhoid fever due to a lactose-fermenting and multiple drug-resistant S. typhi strain, manifested 27 days after cholecystectomy. This report describes the clinical course of the illness and characterizes the isolates from the bile, blood, and pus of the patient for their biochemical attributes and antimicrobial susceptibility pattern.
CASE REPORT
Clinical course of the illness. In February 1982, a 45-year-old male developed sudden onset of fever (40°C), headache, nausea, and watery diarrhea lasting for 17 days (18 February to 6 March). The onset of symptoms occurred 27 days after the patient underwent cholecystectomy. Three days after the onset, the patient was treated with cephalothin (4 g ) and tobramycin (120 mg) per day. Cephalexin (4 g) and cefmetazole (4 g) were later administered. Despite the treatment with these four drugs, he was still febrile with headache and nausea at each peak of the fever. He had proteinuria and also suffered from watery diarrhea one to five times each day during this febrile period. The two lactose-nonfermenting strains were identified correctly with all six systems. The profile numbers obtained from the three lactosefermenting strains were not included in the profile number code book of API-20E, Biotest-I, ID test, and Minitek Enterobacteriaceae II revised (Table 3) . Moreover the profile number of strain 11926 in Enterotube II system corresponded to Escherichia coli. The Minitek Enterics (1977) alone identified the three lactose-fermenting S. typhi strains correctly.
The three lactose-positive isolates were resistant to six drugs, whereas the lactose-negative dissociant was resistant only to two drugs ( Table  4) .
The MICs of 18 antimicrobial agents for the five strains are listed in Table 5 . The three lactose-fermenting strains were significantly more resistant to CP, ABPC, AMPC, SMX, TMP, TOB, GM, and KM. In contrast, the lactose-negative dissociant strain 11925 was resistant only to CP.
Serological examination revealed that the three lactose-positive and one lactose-negative strains possessed the antigenic formula of S. typhi, 9, 12, Vi:d:-.
The three lactose-fermenting and one lactosenonfermenting dissociant strains were deter- (3), was an isolate from the stool of a gastroenteritis patient (7) . A lactose-fermenting S. typhi strain, obtained as the etiological agent of a case of laboratory-acquired typhoid fever, was thought to be identical to a strain 643 lac+ harboring the (lac+) plasmid from ST-2 strain (10). Thus, there has been no report of any case of typhoid fever due to a naturally occurring lactose-fermenting S. typhi, despite frequent reports of salmonellosis caused by lactose-fermenting strains from various countries (1, 9, 14, 24).
As with strain ST-2, the lactose-fermenting ability of a S. newport strain in Canada was plasmid mediated and transmissible (1) . On the other hand, the lactose-fermenting characteristics of the Brazilian S. typhimurium and S. oranienburg could be transferred to S. typhi 643 only after mobilization (14) . Spontaneous segregation of lactose-nonfermenting colonies suggests the instability and extrachromosomal nature of lactose-fermenting ability of our three isolates. Our preliminary experiments indicate that their lactose-fermenting and part of their drug resistance capabilities are transmissible.
Lactose 18, 1983 on August 27, 2017 by guest http://jcm.asm.org/ Downloaded from plied in Japan usually after isolates have demonstrated metabolic characteristics compatible with Salmonella. In the case of aberrant strains, such as these lactose-fermenting strains of S.
typhi, the serological identification may not be performed.
To overcome the difficulties in isolating and identifying lactose-fermenting S. typhi strains, a bismuth-sulfite agar (5, 22) and a lysine-iron agar (5, 11, 22) should be used in clinical bacteriology laboratories. Our strains would have been properly identified earlier had a presumptive clinical diagnosis of typhoid fever been available.
The fact that fermentation products of carbohydrates by salmonellae masked the iron sulfide indicator (6) was also confirmed in our lactosefermenting S. typhi strain. The mechanism of this interesting phenomenon remains to be solved.
Chloramphenicol has long been known as the drug of choice for the treatment of typhoid fever with ABPC (18, 20) , AMPC (17) , and co-trimoxazole (SMX-TMP) (21) as alternatives. However, our three lactose-fermenting S. typhi strains were resistant in vitro to all four drugs. CEX and CMZ, though their MICs for the three isolates were 3.1 and 0.4 ,ug/ml, respectively, showed no appreciable clinical result. The MICs of LMOX and FOM were 0.1 and 25 ,ug/ml, respectively. Physicians in Japan feel that FOM is effective against salmonellae but that cephalosporin derivatives are not. Since the combination was used in this instance, it is not possible to ascribe effectiveness to either drug alone.
Chloramphenicol-resistant strains of S. typhi were isolated in Chile in 1966 and in Aden and Kuwait in 1967. A large outbreak of CP-resistant typhoid fever occurred first in Mexico in 1972 to 1973 and then in India, Vietnam, and Thailand. The isolates in Kuwait were resistant to CP and ABPC (2) . The isolates in Mexico (10, 23) , India (19) , Vietnam (7), and Thailand (12) exhibited a four-drug resistance: to CP, TC, SU, and SM (2). In Japan, there have been no CP-resistant strains of S. typhi isolated from the blood (16).
This case of typhoid fever due to a lactosefermenting and multiple drug-resistant strain of S. typhi, described here, developed 27 days after a successful cholecystectomy. Since the bile of this patient was not cultured until the onset of his febrile illness, it cannot be known whether the patient carried S. typhi in his biliary tract at the time of cholecystectomy. The patient and his family did not have any febrile illness or any overseas travel until this instance. Furthermore, the 28-day postoperative period for the appearance of fever seems too long for an infection of endogenous origin, suggesting the possibility of a nosocomial acquisition of typhoid fever. In December 1981, a female patient with cholelithiasis was admitted to the same ward. She was found to be an asymptomatic carrier of S. typhi by a positive culture of bile specimen made at the time of her operation. Although the isolate (SN172) was neither lactose fermenting nor drug resistant, it was identified as phage type Ml, similar to the above-mentioned lactose-fermenting isolates in March 1982. After the case due to a lactose-fermenting strain occurred in February 1982, there has been no additional clinical case of typhoid fever in the hospital.
